US 6506799
Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds
expired A61PA61P1/18A61P13/12
Quick answer
US patent 6506799 (Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds) held by Esperion Therapeutics, Inc. expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Esperion Therapeutics, Inc.
- Grant date
- Tue Jan 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P1/18, A61P13/12, A61P15/10, A61P25/28